[1]
“Prevention of acute kidney injury in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: comparison of atorva­­statin and rosuvastatin in «case – control» study”, UJC, no. 1, pp. 16–24, Mar. 2017, Accessed: Nov. 24, 2024. [Online]. Available: https://ucardioj.com.ua/index.php/UJC/article/view/85